Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis
Brain · 2024
DOI: 10.1093/brain/awae288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Rachel J Sharkey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Glymphatic System, Diffusion Tensor Imaging. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ALS Society of Canada, Barry Barrett Foundation, Rose Family Foundation.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of motor neurons in the brain and spinal cord. Accumulation of misfolded proteins is central to the pathogenesis of ALS and the glymphatic system is emerging as a potential therapeutic target to reduce proteinopathy. Using diffusion tensor imaging analysis along the perivascular spaces (DTI-ALPS) to assess glymphatic function, we performed a longitudinal analysis of glymphatic function in ALS and compared it to a disorder in the motor neuron disease spectrum, primary lateral sclerosis (PLS). From a cohort of 45 participants from the Calgary site in the CALSNIC study (Canadian ALS Neuroimaging Consortium), including 18 ALS, 5 PLS and 22 control participants, DTI-ALPS was analysed and correlated to clinical features (age, sex, disease presentation, disease severity and progression rate) and white matter hyperintensity burden. This included longitudinal measurements at three time points, 4 months apart. The DTI-ALPS index was reduced in ALS participants compared with PLS and control participants across all three time points. There was no association with clinical factors; however, the index tended to decline with advancing age. Our study suggests heterogeneity in glymphatic dysfunction in motor neuron diseases that may be related to the underlying pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Seaman Family MR Research Centre, Foothills Medical Centre, Calgary, AB T2N 4N1, Canada.
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.
ORCID-Profile: Bradley G Goodyear, Minh Dang Nguyen, Gerald Pfeffer
Förderung
- ALS Society of Canada
- Barry Barrett Foundation
- Rose Family Foundation
- Hotchkiss Brain Institute
- CIHR
- Brain Canada Foundation
- Canadian Institutes of Health Research
Zitieren
APA
Sharkey, R. J., Cortese, F., Goodyear, B. G., Korngut, L. W., Jacob, S. M., Sharkey, K. A., Kalra, S., Nguyen, M. D., Frayne, R., & Pfeffer, G. (2024). Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis. Brain. https://doi.org/10.1093/brain/awae288
Vancouver
Sharkey RJ, Cortese F, Goodyear BG, Korngut LW, Jacob SM, Sharkey KA, et al. Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis. Brain. 2024. doi:10.1093/brain/awae288
BibTeX
@article{Sharkey2024,
author = {Sharkey, Rachel J and Cortese, Filomeno and Goodyear, Bradley G and Korngut, Lawrence W and Jacob, Sarah M and Sharkey, Keith A and Kalra, Sanjay and Nguyen, Minh Dang and Frayne, Richard and Pfeffer, Gerald},
title = {Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae288}
}
EUVIMED